SCHEMBL697981

SCHEMBL697981

CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)NCC(=O)c1ccc(Oc2cccc(C(=O)CNC(=O)[C@@H]3CCCN3C(C)(C)C)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
NPC1 O15118 2/20 0.47
LMNA P02545 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
USP30 Q70CQ3 1/20 0.42
KDM4E B2RXH2 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
RAB9A P51151 1/20 0.42
POLB P06746 2/20 0.41
HRH2 P25021 1/20 0.41
HRH1 P35367 1/20 0.41
GHSR Q92847 2/20 0.41
UCHL1 P09936 1/20 0.41
SIRT2 Q8IXJ6 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564702 0.95 NPC1 (0.52) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL564701 0.95 NPC1 (0.52) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL883239 0.88 NPC1 (0.59) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL883027 0.87 HTR2C (0.46) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL10182646 0.81 USP30 (0.58) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL564703 0.81 ALDH1A1 (0.44) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL11910976 0.81 NPC1 (0.60) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL14845515 0.81 NPC1 (0.60) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL882753 0.80 ALDH1A1 (0.49) ALDH1A1NPC1LMNANPSR1SMN1; SMN2
SCHEMBL23247917 0.80 SMN1; SMN2 (0.53) ALDH1A1NPC1LMNANPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421855-A1 DIARYL ETHERS Tibotec Pharmaceuticals (IE) 2012-02-29 EP disclosed
WO-2010122162-A1 DIARYL ETHERS TIBOTEC PHARMACEUTICALS (IE) 2010-10-28 WO disclosed